DexCom Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	4,818	4,662	4,033	3,622	2,910	2,449
Revenue Growth (YoY)	16.15%	15.60%	11.34%	24.49%	18.84%	27.08%
Cost of Revenue	1,855	1,860	1,595	1,333	1,027	768
Gross Profit	2,963	2,802	2,438	2,289	1,883	1,681
Selling, General & Admin	1,331	1,291	1,286	1,185	1,008	810.5
Research & Development	599.2	599.1	552.4	505.8	484.2	604.2
Total Operating Expenses	1,930	1,890	1,838	1,691	1,492	1,415
Operating Income	1,033	911.8	600	597.7	391.2	265.8
Other Non-Operating Income (Expense)	170.2	176.6	109	112.7	-0.4	-9
Total Non-Operating Income (Expense)	170.2	176.6	109	112.7	-0.4	-9
Pretax Income	1,204	1,088	709	710.4	390.8	256.8
Provision for Income Taxes	273.2	252.1	132.8	168.9	49.6	39.9
Net Income	930.4	836.3	576.2	541.5	341.2	216.9
Net Income to Common	930.4	836.3	576.2	541.5	341.2	216.9
Net Income Growth	73.84%	45.14%	6.41%	58.70%	57.31%	-60.54%
Shares Outstanding (Basic)	389	390	394	386	389	387
Shares Outstanding (Diluted)	402	406	413	426	428	429
Shares Change (YoY)	-2.02%	-1.75%	-3.01%	-0.47%	-0.30%	2.00%
EPS (Basic)	2.40	2.14	1.46	1.40	0.88	0.56
EPS (Diluted)	2.34	2.09	1.42	1.30	0.82	0.53
EPS Growth	74.63%	47.18%	9.23%	58.54%	54.72%	-60.15%
Shares Outstanding	385.9	384.8	390.7	385.4	386.3	384.6
Free Cash Flow	1,429	1,077	630.7	511.9	304.7	53.3
Free Cash Flow Growth	32.70%	70.79%	23.21%	68.00%	471.67%	-80.73%
Free Cash Flow Per Share	3.56	2.66	1.53	1.20	0.71	0.12
Gross Margin	61.50%	60.10%	60.46%	63.19%	64.72%	68.63%
Operating Margin	21.45%	19.56%	14.88%	16.50%	13.44%	10.86%
Profit Margin	19.31%	17.94%	14.29%	14.95%	11.73%	8.86%
FCF Margin	29.67%	23.11%	15.64%	14.13%	10.47%	2.18%
EBITDA	1,292	1,164	817.7	783.7	547.1	367.8
EBITDA Margin	26.82%	24.96%	20.28%	21.64%	18.80%	15.02%
EBIT	1,033	911.8	600	597.7	391.2	265.8
EBIT Margin	21.45%	19.56%	14.88%	16.50%	13.44%	10.86%
Effective Tax Rate	22.70%	23.16%	18.73%	23.78%	12.69%	15.54%

SEC Filings: 10-K · 10-Q